Large Scale RNAi Reveals the Requirement of Nuclear Envelope Breakdown for Nuclear Import of Human Papillomaviruses

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Aydin, Inci ^a,b   Weber, Susanne ^a,b   Snijder, Berend ^c   Samperio Ventayol, Pilar ^a,b   Kühbacher, Andreas ^d   Becker, Miriam ^a,b   Day, Patricia M ^e   Schiller, John T ^e   Kann, Michael ^f   Pelkmans, Lucas ^c   Helenius, Ari ^d   Schelhaas, Mario ^a,b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Cluster of Excellence EXC1003 Cells in Motion ^*  (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d ETH ZURICH   (Switzerland)

^e NATIONAL CANCER INSTITUTE   (United States)

^f University Victor Segalen   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL NUCLEUS MEMBRANE; COMPUTER NETWORK; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INTERPHASE; MICROSCOPY; MITOSIS; NUCLEAR IMPORT; PAPILLOMA VIRUS; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; ACTIVE TRANSPORT; CELL CULTURE; CELL NUCLEUS; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ONCOPROTEIN; VIRUS DNA;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; CELLS, CULTURED; DNA, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MITOSIS; NUCLEAR ENVELOPE; ONCOGENE PROTEINS, VIRAL; RNA INTERFERENCE;

EID: 84901660890     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004162     Document Type: Article

References (86)

1. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, et al. (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30 (Suppl 5): F55-70.
2. Bosch FX, de Sanjose S, (2003) Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr (31): 3-13.
3. Schiller JT, Castellsague X, Garland SM, (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30 (Suppl 5): F123-138.
4. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, et al. (2008) Arrangement of L2 within the Papillomavirus capsid. J Virol 82: 5190-5197.
5. Buck CB, Pastrana DV, Lowy DR, Schiller JT, (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
6. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT, (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-2846.
7. Buck CB, Thompson CD (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chapter 26: Unit 26 21.
8. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M, (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75: 1565-1570.
9. Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, et al. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83: 2067-2074.
10. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, et al. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274: 5810-5822.
11. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM, (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 106: 20458-20463.
12. Cerqueira C, Liu Y, Kuhling L, Chai W, Hafezi W, et al. (2013) Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol 15: 1818-1836.
13. Richards KF, Bienkowska-Haba M, Dasgupta J, Chen XS, Sapp M, (2013) Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol 87: 11426-11437.
14. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81: 10970-10980.
15. Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT, (2008) Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol 82: 4638-4646.
16. Bienkowska-Haba M, Patel HD, Sapp M, (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5: e1000524.
17. Richards RM, Lowy DR, Schiller JT, Day PM, (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103: 1522-1527.
18. Day PM, Lowy DR, Schiller JT, (2008) Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 82: 12565-12568.
19. Selinka HC, Giroglou T, Nowak T, Christensen ND, Sapp M, (2003) Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol 77: 12961-12967.
20. Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, et al. (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81: 8784-8792.
21. Surviladze Z, Dziduszko A, Ozbun MA, (2012) Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 8: e1002519.
22. Woodham AW, Da Silva DM, Skeate JG, Raff AB, Ambroso MR, et al. (2012) The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One 7: e43519.
23. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, et al. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71: 2449-2456.
24. McMillan NA, Payne E, Frazer IH, Evander M, (1999) Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 261: 271-279.
25. Yoon CS, Kim KD, Park SN, Cheong SW, (2001) alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 283: 668-673.
26. Dziduszko A, Ozbun MA, (2013) Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol 87: 7502-7515.
27. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, et al. (2008) Clathrin- and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3: e3313.
28. Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, et al. (2013) Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. J Virol 87: 3435-3446.
29. Florin L, Sapp M, Spoden GA, (2012) Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol 201: 437-448.
30. Day PM, Lowy DR, Schiller JT, (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307: 1-11.
31. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, et al. (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog 8: e1002657.
32. Spoden G, Kuhling L, Cordes N, Frenzel B, Sapp M, et al. (2013) Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol 87: 7765-7773.
33. Day PM, Thompson CD, Schowalter RM, Lowy DR, Schiller JT, (2013) Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection. J Virol 87: 3862-3870.
34. Lipovsky A, Popa A, Pimienta G, Wyler M, Bhan A, et al. (2013) Genome-wide siRNA screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc Natl Acad Sci U S A 110: 7452-7457.
35. Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M, (2012) Cyclophilins Facilitate Dissociation of the HPV16 Capsid Protein L1 from the L2/DNA Complex Following Virus Entry. J Virol 86: 9875-87.
36. Kamper N, Day PM, Nowak T, Selinka HC, Florin L, et al. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80: 759-768.
37. Ishii Y, Tanaka K, Kondo K, Takeuchi T, Mori S, et al. (2010) Inhibition of nuclear entry of HPV16 pseudovirus-packaged DNA by an anti-HPV16 L2 neutralizing antibody. Virology 406: 181-188.
38. Day PM, Baker CC, Lowy DR, Schiller JT, (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101: 14252-14257.
39. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF, (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5: e1000318.
40. Cherry S, (2009) What have RNAi screens taught us about viral-host interactions? Curr Opin Microbiol 12: 446-452.
41. Snijder B, Sacher R, Ramo P, Liberali P, Mench K, et al. (2012) Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol 8: 579.
42. Fothergill T, McMillan NA, (2006) Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology 352: 319-328.
43. Schneider MA, Spoden GA, Florin L, Lambert C, (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13: 32-46.
44. Surviladze Z, Sterk RT, DeHaro SA, Ozbun MA, (2013) Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol 87: 2508-2517.
45. Mercer J, Snijder B, Sacher R, Burkard C, Bleck CK, et al. (2012) RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep 2: 1036-1047.
46. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
47. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568.
48. Steigemann P, Wurzenberger C, Schmitz MH, Held M, Guizetti J, et al. (2009) Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136: 473-484.
49. Heim R, Prasher DC, Tsien RY, (1994) Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci U S A 91: 12501-12504.
50. Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, et al. (1999) Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286: 971-974.
51. Kapoor TM, Mayer TU, Coughlin ML, Mitchison TJ, (2000) Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. J Cell Biol 150: 975-988.
52. Guttinger S, Laurell E, Kutay U, (2009) Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 10: 178-191.
53. Drobni P, Mistry N, McMillan N, Evander M, (2003) Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry. Virology 310: 163-172.
54. Sapp M, Kraus U, Volpers C, Snijders PJ, Walboomers JM, et al. (1994) Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol 75 (Pt 12): 3375-3383.
55. Whittaker GR, Kann M, Helenius A, (2000) Viral entry into the nucleus. Annu Rev Cell Dev Biol 16: 627-651.
56. Greber UF, Fassati A, (2003) Nuclear import of viral DNA genomes. Traffic 4: 136-143.
57. Cohen S, Au S, Pante N, (2011) How viruses access the nucleus. Biochim Biophys Acta 1813: 1634-1645.
58. Kwant MM, van der Vliet PC, (1980) Differential effect of aphidicolin on adenovirus DNA synthesis and cellular DNA synthesis. Nucleic Acids Res 8: 3993-4007.
59. Spadari S, Focher F, Sala F, Ciarrocchi G, Koch G, et al. (1985) Control of cell division by aphidicolin without adverse effects upon resting cells. Arzneimittelforschung 35: 1108-1116.
60. Ojala PM, Sodeik B, Ebersold MW, Kutay U, Helenius A, (2000) Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol 20: 4922-4931.
61. Hafezi W, Lorentzen EU, Eing BR, Muller M, King NJ, et al. (2012) Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog 8: e1002679.
62. Walther TC, Fornerod M, Pickersgill H, Goldberg M, Allen TD, et al. (2001) The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. EMBO J 20: 5703-5714.
63. Suzuki Y, Craigie R, (2007) The road to chromatin- nuclear entry of retroviruses. Nat Rev Microbiol 5: 187-196.
64. Porwal M, Cohen S, Snoussi K, Popa-Wagner R, Anderson F, et al. (2013) Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis. PLoS Pathog 9: e1003671.
65. Held M, Schmitz MH, Fischer B, Walter T, Neumann B, et al. (2010) CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging. Nat Methods 7: 747-754.
66. Seksek O, Biwersi J, Verkman AS, (1997) Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J Cell Biol 138: 131-142.
67. Darshan MS, Lucchi J, Harding E, Moroianu J, (2004) The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J Virol 78: 12179-12188.
68. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, et al. (2010) Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 12: 886-893.
69. Tanudji M, Shoemaker J, L'Italien L, Russell L, Chin G, et al. (2004) Gene silencing of CENP-E by small interfering RNA in HeLa cells leads to missegregation of chromosomes after a mitotic delay. Mol Biol Cell 15: 3771-3781.
70. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, et al. (2009) Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 5: e1000437.
71. Panda D, Cherry S, (2012) Cell-based genomic screening: elucidating virus-host interactions. Curr Opin Virol 2: 784-792.
72. Florin L, Becker KA, Lambert C, Nowak T, Sapp C, et al. (2006) Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol 80: 6691-6696.
73. Bordeaux J, Forte S, Harding E, Darshan MS, Klucevsek K, et al. (2006) The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J Virol 80: 8259-8262.
74. Elis E, Ehrlich M, Prizan-Ravid A, Laham-Karam N, Bacharach E, (2012) p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes. PLoS Pathog 8: e1003103.
75. McBride AA, (2013) The papillomavirus E2 proteins. Virology 445: 57-79.
76. Barksdale SK, Baker CC, (1993) Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J Virol 67: 5605-5616.
77. Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, et al. (2004) Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321: 205-216.
78. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13: 857-861.
79. Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, et al. (2005) Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology 337: 365-372.
80. Schelhaas M, Ewers H, Rajamaki ML, Day PM, Schiller JT, et al. (2008) Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog 4: e1000148.
81. McLaughlin-Drubin ME, Meyers C, (2005) Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med 119: 171-186.
82. Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C, (2011) Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One 6: e22427.
83. Cerqueira C, Liu Y, Kuhling L, Chai W, Hafezi W, et al. (2013) Heparin increases the infectivity of Human Papillomavirus Type 16 independent of cell surface proteoglycans and induces L1 epitope exposure. Cell Microbiol 15: 1818-36.
84. Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, et al. (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85: 4198-4211.
85. Jones TR, Kang IH, Wheeler DB, Lindquist RA, Papallo A, et al. (2008) CellProfiler Analyst: data exploration and analysis software for complex image-based screens. BMC Bioinformatics 9: 482.
86. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7: R100.